Successful Treatment of an Infected Zenith Fenestrated Endograft Without Explantation

S. Keisin Wang, Andres Fajardo, Raghu Motaganahalli, Alok K. Gupta

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Current surgical dogma for infected aortic endografts consists of complete explantation concurrent with revascularization via extra-anatomic bypass or in situ infection-resistant conduit. However, this treatment paradigm is associated with high rates of postoperative mortality and major morbidity. Therefore, patients with prohibitive operative risk are often not offered surgical intervention. In the following manuscript, we report the successful treatment of an 85-year-old gentleman with a fenestrated aortic endograft (Cook Medical, Bloomington, Indiana) infected secondary to the formation of an aortoenteric fistula with primary bowel repair, washout, and lifelong antibiotics and followed for nearly 2 years after intervention. Therefore, this nonexplantation approach can be considered for patients who may otherwise have no surgical recourse.

Original languageEnglish (US)
JournalVascular and Endovascular Surgery
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Manuscripts
Fistula
Anti-Bacterial Agents
Morbidity
Mortality
Therapeutics
Infection

Keywords

  • AAA
  • explantation
  • FEVAR
  • graft
  • infection
  • nonoperative

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Successful Treatment of an Infected Zenith Fenestrated Endograft Without Explantation. / Wang, S. Keisin; Fajardo, Andres; Motaganahalli, Raghu; Gupta, Alok K.

In: Vascular and Endovascular Surgery, 01.01.2018.

Research output: Contribution to journalArticle

@article{0c06edfbb112491799908969599c36c3,
title = "Successful Treatment of an Infected Zenith Fenestrated Endograft Without Explantation",
abstract = "Current surgical dogma for infected aortic endografts consists of complete explantation concurrent with revascularization via extra-anatomic bypass or in situ infection-resistant conduit. However, this treatment paradigm is associated with high rates of postoperative mortality and major morbidity. Therefore, patients with prohibitive operative risk are often not offered surgical intervention. In the following manuscript, we report the successful treatment of an 85-year-old gentleman with a fenestrated aortic endograft (Cook Medical, Bloomington, Indiana) infected secondary to the formation of an aortoenteric fistula with primary bowel repair, washout, and lifelong antibiotics and followed for nearly 2 years after intervention. Therefore, this nonexplantation approach can be considered for patients who may otherwise have no surgical recourse.",
keywords = "AAA, explantation, FEVAR, graft, infection, nonoperative",
author = "Wang, {S. Keisin} and Andres Fajardo and Raghu Motaganahalli and Gupta, {Alok K.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/1538574418774663",
language = "English (US)",
journal = "Vascular and Endovascular Surgery",
issn = "1538-5744",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Successful Treatment of an Infected Zenith Fenestrated Endograft Without Explantation

AU - Wang, S. Keisin

AU - Fajardo, Andres

AU - Motaganahalli, Raghu

AU - Gupta, Alok K.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Current surgical dogma for infected aortic endografts consists of complete explantation concurrent with revascularization via extra-anatomic bypass or in situ infection-resistant conduit. However, this treatment paradigm is associated with high rates of postoperative mortality and major morbidity. Therefore, patients with prohibitive operative risk are often not offered surgical intervention. In the following manuscript, we report the successful treatment of an 85-year-old gentleman with a fenestrated aortic endograft (Cook Medical, Bloomington, Indiana) infected secondary to the formation of an aortoenteric fistula with primary bowel repair, washout, and lifelong antibiotics and followed for nearly 2 years after intervention. Therefore, this nonexplantation approach can be considered for patients who may otherwise have no surgical recourse.

AB - Current surgical dogma for infected aortic endografts consists of complete explantation concurrent with revascularization via extra-anatomic bypass or in situ infection-resistant conduit. However, this treatment paradigm is associated with high rates of postoperative mortality and major morbidity. Therefore, patients with prohibitive operative risk are often not offered surgical intervention. In the following manuscript, we report the successful treatment of an 85-year-old gentleman with a fenestrated aortic endograft (Cook Medical, Bloomington, Indiana) infected secondary to the formation of an aortoenteric fistula with primary bowel repair, washout, and lifelong antibiotics and followed for nearly 2 years after intervention. Therefore, this nonexplantation approach can be considered for patients who may otherwise have no surgical recourse.

KW - AAA

KW - explantation

KW - FEVAR

KW - graft

KW - infection

KW - nonoperative

UR - http://www.scopus.com/inward/record.url?scp=85046760978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046760978&partnerID=8YFLogxK

U2 - 10.1177/1538574418774663

DO - 10.1177/1538574418774663

M3 - Article

C2 - 29734863

AN - SCOPUS:85046760978

JO - Vascular and Endovascular Surgery

JF - Vascular and Endovascular Surgery

SN - 1538-5744

ER -